The role of CNS arousal levels in the management of hyperkinesis : methylphenidate and EEG biofeedback training
Research over the past five years suggests that central nervous system (CNS) arousal level moderates both the severity of the hyperkinetic disorder in children and the degree of therapeutic success anticipated following stimulant drug therapy. It was hypothesized that low and high arousal groups of hyperkinetic children should be differentiated from normal controls on a variety of physiological arousal measures. Relative to high arousal subjects, low arousal subjects were expected to display the most severe pre-treatment behavioral profiles and to benefit most from stimulant drug therapy. Both groups were expected to benefit from biofeedback training of the sensorimotor rhythm (SMR), a 12-14 Hz EEG rhythm recorded over Rolandic cortex. Considerable research associates conditioned increases in this rhythm with voluntary motor inhibition and with the normalization of various EEG and autonomic indices of arousal.
Subjects were twelve hyperkinetic and twelve normal children matched for age, sex, and IQ. CNS arousal indices included the amplitude of auditory evoked cortical responses, the incidence of SMR, the amount of slow wave activity in the background electroencephalogram (EEG), and basal skin resistance (GSR). Indices of somatomotor activity included measures of muscular tone (Electromyogram or EMG), the Stewart teacher questionnaire, and behavioral assessments of short attention span and overactivity in the classroom. The experiment consisted of six phases: I. NO DRUG; II. DRUG ONLY; III. DRUG AND SMR training I; IV. DRUG AND SMR reveral training; V. DRUG AND SMR training II; VI. NO DRUG AND SMR training. All measures were obtained for each subject during pretraining phases I and II and at the end of training phase VI. SMR, background EEG, EMG, and classroom behaviors were systematically recorded in training subjects throughout the study. GSR and evoked cortical responses were also obtained at the end of the first training period (IlI).
High arousal subjects could not be differentiated from the remainder of the hyperkinetic population in pre-training phases I and II. Subjects participating in the biofeedback training sequence were four low arousal hyperkinetic subjects who differed from normal control subjects and the remaining hyperkinetic subjects (hyperkinetic control subjects) in the predicted direction on all measures in the NO DRUG condition (I) and whose physiological and behavioral profiles during the DRUG ONLY phase (II) reflected significant but incomplete remission of symptoms. Constant drug regimens (Ritalin) were maintained during phases II-V and were gradually withdrawn (5mg/week) during phase VI.
The results of several months of SMR training tend to corroborate and extend previous findings. Substantial increases in SMR occurred with progressive training in three of four subjects. Enhanced motor inhibition in the laboratory and classroom accompanied SMR training and was diminished following successful SMR reversal training. The effectiveness of the biofeedback technique is supported by the fact that combining medication and SMR training resulted in substantial improvement above and beyond the effects of drugs alone and that these effects were maintained following withdrawal of the drug. Anticipated changes in evoked cortical responses, GSR, and background EEG during training (IIl) and at the end of the experiment (VI) suggested increases in CNS arousal level. Three findings minimize the role of extraneous influences such as maturation on treatment outcomes: 1) the reductions in positive treatment effects following SMR counterconditioning; 2) the significant posttreatment (VI) improvement from DRUG ONLY (II) in low arousal subjects relative to changes over that period in hyperkinetic and normal control subjects; and 3) the selectivity of changes exhibited in effectively trained subjects. With the exception of GSR, teacher reported symptoms, and behavioral measures of distractability, subjects demonstrating acquisition of training could not be distinguished behaviorally or physiologically from normal controls at the end of the experiment.
Individual differences in training subjects were discussed in terms of pre-treatment physiological and behavioral profiles. The subject who failed to demonstrate acquisition differed from the others in being excessively distractible. Otherwise, the similarity between effectively trained subjects is encouraging. Generally, subjects exhibiting the most severe pre-treatment arousal and behavioral profiles responded most favorably to both treatments. The lowest pre-treatment incidence of SMR and highest levels of motor excitability most effectively predicted subsequent response to treatment. These findings reaffirm the relationship between SMR and motor inhibition and suggest that the arousal changes observed may be a secondary outcome of motor control. Nevertheless, a much larger population of hyperkinetic subjects is required before any substantive conclusion is possible about the technique's utility or its basis in central mechanism of arousal or motor control.
Thesis76b.S366.pdf
5.56 MB
Adobe PDF
4ce6e3073c40782dbb4ba977105a7ceb